Drug
Enarodustat
Enarodustat is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph phase_3
2
50%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Terminated(1)
Detailed Status
Recruiting2
Withdrawn1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 32 (66.7%)
Phase 41 (33.3%)
Trials by Status
withdrawn125%
not_yet_recruiting125%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
recruiting
Real-World Study of Enarodustat for Anemia in Non-Dialysis CKD Patients
NCT07741279
withdrawnphase_3
Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA
NCT07522996
not_yet_recruitingphase_3
Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA
NCT07548671
recruitingphase_4
Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
NCT06725810
Clinical Trials (4)
Showing 4 of 4 trials
NCT07741279
Real-World Study of Enarodustat for Anemia in Non-Dialysis CKD Patients
NCT07522996Phase 3
Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA
NCT07548671Phase 3
Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA
NCT06725810Phase 4
Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4